| 000 | 01040 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515075426.0 | ||
| 264 | 0 | _c20080306 | |
| 008 | 200803s 0 0 eng d | ||
| 022 | _a1465-542X | ||
| 024 | 7 |
_a10.1186/bcr1736 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColditz, Graham A | |
| 245 | 0 | 0 |
_aDecline in breast cancer incidence due to removal of promoter: combination estrogen plus progestin. _h[electronic resource] |
| 260 |
_bBreast cancer research : BCR _c2007 |
||
| 300 |
_a108 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
| 650 | 0 | 4 |
_aEstrogens _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProgestins _xadverse effects |
| 773 | 0 |
_tBreast cancer research : BCR _gvol. 9 _gno. 4 _gp. 108 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/bcr1736 _zAvailable from publisher's website |
| 999 |
_c17199182 _d17199182 |
||